Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$42.05 - $47.77 $142,213 - $161,558
3,382 Added 6.23%
57,657 $2.51 Million
Q1 2022

May 05, 2022

BUY
$40.23 - $47.74 $710,260 - $842,849
17,655 Added 48.21%
54,275 $2.45 Million
Q4 2021

Feb 08, 2022

BUY
$38.88 - $45.31 $261,973 - $305,298
6,738 Added 22.55%
36,620 $1.62 Million
Q3 2021

Nov 04, 2021

BUY
$38.79 - $43.16 $83,514 - $92,923
2,153 Added 7.76%
29,882 $1.14 Million
Q2 2021

Aug 04, 2021

BUY
$36.52 - $41.46 $162,806 - $184,828
4,458 Added 19.16%
27,729 $1.1 Million
Q1 2021

May 11, 2021

BUY
$34.27 - $40.01 $82,727 - $96,584
2,414 Added 11.57%
23,271 $831,000
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $7,325 - $8,587
-215 Reduced 1.02%
20,857 $768,000
Q3 2020

Nov 12, 2020

SELL
$38.11 - $42.99 $4,535 - $5,115
-119 Reduced 0.56%
21,072 $793,000
Q2 2020

Jul 31, 2020

SELL
$37.87 - $43.58 $52,109 - $59,966
-1,376 Reduced 6.1%
21,191 $864,000
Q1 2020

May 06, 2020

BUY
$32.47 - $48.83 $84,616 - $127,250
2,606 Added 13.06%
22,567 $855,000
Q4 2019

Feb 13, 2020

BUY
$42.0 - $48.25 $200,970 - $230,876
4,785 Added 31.53%
19,961 $938,000
Q3 2019

Nov 06, 2019

SELL
$40.46 - $43.52 $21,120 - $22,717
-522 Reduced 3.33%
15,176 $648,000
Q2 2019

Aug 07, 2019

BUY
$39.4 - $42.7 $47,989 - $52,008
1,218 Added 8.41%
15,698 $628,000
Q1 2019

May 13, 2019

BUY
$38.57 - $42.69 $117,291 - $129,820
3,041 Added 26.58%
14,480 $0
Q4 2018

Feb 08, 2019

BUY
$37.8 - $42.69 $175,770 - $198,508
4,650 Added 68.49%
11,439 $437,000
Q3 2018

Nov 14, 2018

BUY
$39.75 - $42.69 $269,862 - $289,822
6,789 New
6,789 $273,000
Q4 2017

Feb 07, 2018

SELL
$35.34 - $41.9 $239,852 - $284,375
-6,787 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$39.44 - $41.55 $59,712 - $62,906
1,514 Added 28.71%
6,787 $276,000
Q2 2017

Aug 15, 2017

BUY
N/A
5,273
5,273 $227,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.